Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study.

Biomolecules · 2025 · PMC12383602 · PMID 40867519

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rs10733113 AG polymorphism was found more frequently in AD patients (41.2%) than in HC (15.4%), but this difference did not reach statistical significance (pf = 0.2). 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.